PCK1
PCK1 (phosphoenolpyruvate carboxykinase 1, also known as PEPCK-C) is the cytosolic, GTP-dependent enzyme that acts as the rate-limiting step of gluconeogenesis. It converts oxaloacetate to phosphoenolpyruvate and, when phosphorylated, also works as a protein kinase. Browse Assay Genie's current range of PCK1 research reagents below, or read on for the biology behind the target.
PCK1 is a cytosolic phosphoenolpyruvate carboxykinase that catalyses the reversible decarboxylation and phosphorylation of oxaloacetate (OAA), using GTP and releasing carbon dioxide and GDP. It is the rate-limiting enzyme in gluconeogenesis and a main control point for its regulation. By regulating cataplerosis and anaplerosis, it helps set the levels of metabolic intermediates in the citric acid cycle. At low glucose levels it converts oxaloacetate to phosphoenolpyruvate (PEP), the rate-limiting step in making glucose from lactate and other citric acid cycle-derived precursors. At high glucose levels it drives the anaplerotic conversion of PEP back to oxaloacetate.
The PCK1 gene encodes a member of the phosphoenolpyruvate carboxykinase [GTP] family, placed in the HGNC decarboxylases gene group. Its expression can be regulated by insulin, glucocorticoids, glucagon, cAMP and diet. The protein is found in the cytosol, and a mitochondrial isozyme, encoded by a separate gene (PCK2), has also been characterised. Mouse and rat each have a Pck1 ortholog. The protein was formerly listed as phosphoenolpyruvate carboxykinase 1 (soluble).
PCK1 has roles beyond carbohydrate metabolism. When phosphorylated at Ser-90 by AKT1, its affinity for oxaloacetate falls and it acquires an atypical serine protein kinase activity that uses GTP as the phosphate donor. In this form it moves to the endoplasmic reticulum and phosphorylates INSIG1 and INSIG2. This disrupts their interaction with SCAP, promotes nuclear translocation of SREBP proteins and drives transcription of lipogenesis-related genes. PCK1 is also up-regulated in memory CD8(+) T-cells, where the PEP it generates feeds glycogen and the pentose phosphate pathway, which is essential for their homeostasis. Defects in the gene cause cytosolic phosphoenolpyruvate carboxykinase deficiency.
PCK1 is the rate-limiting enzyme that converts oxaloacetate to phosphoenolpyruvate, making it a central focus for studying glucose production from lactate and other precursors.
Its expression responds to insulin, glucocorticoids, glucagon, cAMP and diet, so PCK1 is widely used to examine hormonal and nutritional control of metabolism.
Phosphorylated PCK1 acts as a protein kinase on INSIG1 and INSIG2, linking AKT1 signalling to SREBP activation and lipogenic gene transcription.
PCK1 is up-regulated in memory CD8(+) T-cells, where gluconeogenesis supports glycogen and pentose phosphate pathway flux needed for their homeostasis.
PCK1 catalyses the GTP-dependent conversion of oxaloacetate to phosphoenolpyruvate and is the rate-limiting enzyme of gluconeogenesis. It also regulates cataplerosis and anaplerosis in the citric acid cycle. When phosphorylated at Ser-90, it additionally acts as a protein kinase that regulates lipogenesis.
PCK1 is also called PEPCK-C, for cytosolic phosphoenolpyruvate carboxykinase. UniProt names it phosphoenolpyruvate carboxykinase, cytosolic [GTP], and an earlier HGNC name was phosphoenolpyruvate carboxykinase 1 (soluble). It is distinct from the mitochondrial isozyme encoded by PCK2.
Defects in the PCK1 gene cause cytosolic phosphoenolpyruvate carboxykinase deficiency. The gene has orthologs named Pck1 in both mouse and rat, so rodent models are commonly used; check the datasheet of any product for its validated reactivity.
The mitochondrial isozyme PCK2 and other targets in gluconeogenesis and metabolic regulation with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P35558; product specifications from Assay Genie datasheets.